Kaslow RA, Ostrow DG, Detels R., Phair JP, Polk BF, Rinaldo CRThe Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. American Journal of Epidemiology1987; 126: 310-18.
2.
Grodstein F. , Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJA prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Annals of Internal Medicine2000; 133: 933-41.
3.
Grabar SV, Le Moing V., Goujard C., Leport C., Kazatchkine MD, Costagliola D., Weiss L.Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy . Annals of Internal Medicine2000; 133: 401-10.
4.
Robins JMMarginal structural models. 1997 Proceedings of the Section on Bayesian Statistical Science. American Statistical Association, Alexandria, VA, 1998 : 1-10.
5.
Robins JMMarginal structural models versus structural nested models as tools for causal inference. In: Halloran E, Berry D, eds. Statistical Models in Epidemiology: The Environment and Clinical Trials. Springer-Verlag, New York, 1999: 95-134.
6.
Robins JM, Rotnitzky A., Zhao LPAnalysis of semiparametric regression models for repeated outcomes in the presence of missing data. Journal of the American Statsitical Association1995; 90: 106-21.
7.
Hernán MA, Brumback B., Robins JMEstimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in Medicine2002; 21: 1689-709.
8.
Cole SR, Hernán MA, Margolick JB, Cohen MH, Robins JMMarginal structural models to estimate the effect of highly active antiretroviral therapy initiation on CD4 cell count. American Journal of Epidemiology2005; 162: 471-78.
9.
Robins JM, Hernán MAEstimation of the causal effects of time-varying exposures. In: Advances in Longitudinal Data Analysis. Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, eds. New York, Chapman and Hall/ CRC Press; 2008.
10.
Robins JMA new approach to causal inference in mortality studies with a sustained exposure period Application to the healthy worker survivor effect [published errata appear in Math Modelling, 14, 917-21 (1987)]. Mathematical Modelling1986; 7: 1393-512.
Liang KY, Zeger SLLongitudinal data analysis using generalized linear models. Biometrika1986; 73: 13-22.
13.
Zeger SL, Liang KYLongitudinal data analysis for discrete and continuous outcomes. Biometrics1982; 42: 121-30.
14.
Pierce DAThe asymptotic effect of substituting estimators for parameters in certain types of statistics. The Annals of Statistics1982; 10: 475-78.
15.
Robins JM, Greenland S.Comment on `Causal inference without counterfactuals.'Journal of the American Statistical Association2000; 95: 477-82.
16.
Hernán MA, Taubman SLDoes obesity shorten life? The importance of well defined interventions to answer causal questions. International journal of obesity2008 (in press).
17.
Cole SR, Hernán MA, Robins JM, Anastos K., Chmiel J., Detels R., Ervin C., Feldman J., Greenblatt R., Kingsley L., Lai S., Young M., Cohen M., Muñoz A.Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. American Journal of Epidemiology2003; 158: 687-94.
18.
Hernán MA, Brumback B., Robins JMMarginal structural models to estimate the joint effect of non randomized treatments. Journal of the American Statistical Association2001; 96: 440-48.
19.
Hernán MAConfounding. In: Everitt B, Melnick E, eds. Encyclopedia of Quantitative Risk Assessment. New York, John Wiley; 2008 (in press).
20.
Patel K., Hernán MA, Williams PL, Seeger JD, McIntosh K., Seage GR, for the Pediatric AIDS Clinical Trials Group 219/219C Study Team.Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents infected with HIV-1: a ten year follow-up study. Clinical Infectious Diseases2008; 46: 507-15.
21.
Shepherd BE , Gilbert PB, Jemiai Y., Rotnitzky A.Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials. Biometrics2006; 62: 332-42.
22.
Lin H., Scharfstein DO, Rosenheck RAAnalysis of longitudinal data with irregular, outcome-dependent follow-up . Journal of the Royal Statistical Association2004; 66: 791-813.
23.
Orellana L., Rotnitzky A.Estimation of the effect of dynamic treatment regimes under flexible dynamic visit regimes. Technical Report, Department of Biostatistics, Harvard School of Public Health, 2007.